M/14/004 – Crimson / OCD

Transaction details

The proposed acquisition of sole control of the Ortho Clinical Diagnostics business by Crimson Bermuda Co. Limited has been cleared by the Competition Authority.

Notification date Decision date
Tuesday February 4, 2014 Thursday, February 27, 2014
Parties Involved Business activities
Crimson Bermuda Co. Ltd

Crimson is a company controlled by funds managed by affiliates of The Carlyle Group. Carlyle is a global alternative asset manager.

Ortho Clinical Diagnostics

OCD is a provider of IVD systems.

Economic sector Media merger
The in-vitro diagnostic (IVD) sector. No
Submissions from third parties due by:
Phase 1 Phase 2
Monday, February 17, 2014
Current status: Completed
Cleared (Phase 1)
Authorised Officer Assigned Contact Details
Elaine Cahill

Tel: 01-804 5482, e-mail: 01-804 5482

Media enquiries: MKC Communications: 01 7038600

Return to Merger Notifications

Join our mailing list

Sign up to receive the latest information about mergers:

Read our privacy statement

Haven’t found what you’re looking for?